RESPIRATORY PANEL WITH MDR BY PCR (48)

The RESPIRATORY PANEL WITH MDR BY PCR (48) is a comprehensive molecular assay that simultaneously detects 48 viral and bacterial respiratory pathogens and screens for key multi-drug resistance (MDR) markers using real-time PCR. Samples are collected at home by trained technicians (nasopharyngeal/oropharyngeal swabs) and processed in accredited laboratories to deliver fast, sensitive, and specific results. This service is designed for patients across Dubai and the UAE who require accurate diagnosis for targeted treatment, identification of co-infections, and support for infection-control decisions.

• SARS-CoV-2
• Influenza A
• Influenza B
• Respiratory syncytial virus (RSV)
• Atypical bacteria (Mycoplasma pneumoniae, Chlamydophila pneumoniae)
• MDR markers (key antibiotic resistance genes)

• Persistent fever with cough, sore throat, or shortness of breath
• Severe or worsening respiratory symptoms requiring clinical clarification
• Suspected co-infection or non-resolving infection despite treatment
• Immunocompromised, elderly, or high-risk patients with respiratory signs
• Pre-admission screening, outbreak investigation, or travel-related illness

• Rapid multiplex identification of causative respiratory pathogens
• Comprehensive 48-target coverage to detect co-infections
• MDR detection to guide targeted antibiotic therapy
• Convenient at-home sample collection across Dubai and the UAE
• Supports antimicrobial stewardship and infection‑control measures

• Nasopharyngeal and/or oropharyngeal swab collected by a trained technician at home
• No fasting required; avoid nasal sprays or heavy nasal decongestants immediately before collection
• Preferably collected during the acute phase (within 3–7 days of symptom onset)
• Valid UAE ID and brief clinical history required at time of collection